Si-Bone Initial Public Offering

Cooley advised Si-Bone on its $124.2 million initial public offering of 8,280,000 shares of common stock. Matthew Hemington and John McKenna led the Cooley team advising Si-Bone.

Morgan Stanley and Merrill Lynch acted as the lead book-running managers for the offering. Canaccord Genuity and JMP Securities acted as co-managers for the offering.

Si-Bone is a medical device company that has pioneered a treatment for sacroiliac joint dysfunction that often causes severe lower back pain. The company’s shares now trade on the Nasdaq Global Market under the symbol “SIBN.”

Related Contacts
Matthew Hemington Partner, Palo Alto
John McKenna Partner, Palo Alto
Kate Nichols Associate, Palo Alto
Rose McKinley Associate, Palo Alto
Related Practices & Industries

Capital Markets Public Companies Life Sciences